Daniel Lynch
Director · SpringWorks Therapeutics, Inc.
Individual
- 2025
- Jul 1, 2025
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Daniel Lynch. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Saqib Islam - $2.03M in SWTX purchases and sales on record
- Badreddin Edris - $839K in SWTX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel Lynch?
Daniel Lynch is a corporate insider, tracked as Director of SpringWorks Therapeutics, Inc. (SWTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Daniel Lynch last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2025, one of 2 filings going back to 2025.
